Recently, aspirin was reported to exert its antineoplastic property in glioma by abrogating the tumorigenic effect of the SHH/GLI1 signaling pathway, especially sensitizing the malignant glioma cells resistant to temozolomide (TMZ) therapy [307]. This evidence concerns the gene GLI1 and glioma.